Clinical trial
Influence of Pramipexole Extended Release on Medication Adherence in Real Life Care of Parkinson's Disease
NCT01097421 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Pramipexole Extended Release on Medication Adherence in Real Life Care of Parkinson's Disease
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- Not reported
- Enrollment
- 329 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.